![](/img/cover-not-exists.png)
106PExperience of 22 patients with ROS mutated lung adenocarcinoma treated with crizotinib at a tertiary care center in India
Talreja, V, Pande, NVolume:
29
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy314.044
Date:
September, 2018
File:
PDF, 73 KB
english, 2018